ArticleActa pharmaceutica Sinica. B2021

Development of hedgehog pathway inhibitors by epigenetically targeting GLI through BET bromodomain for the treatment of medulloblastoma.

Xiaohua Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.